SFTPA1 and metabolic dysfunction-associated steatotic liver disease: We observed that both protein and cellular expression of SPA are upregulated in the liver of mice with MASLD, suggesting that SPA may contribute to the pathogenic mechanisms implicated in the development of MASLD.